Table 2.
In vitro cytotoxicity assessment of erythrocyte viability following 24-hour exposures to PG+CAP and commercially used ointments based on dilution and counting with a hemocytometer. Results for each ointment presented are averages ± standard deviation for 5 replicates.
| Treatment | Viable erythrocytes (average ± standard deviation) |
|---|---|
| Saline control | 3.82 ± 0.22 × 106 |
| Base ointment | 3.81 ± 0.16 × 106 |
| PG+CAP | 3.82 ± 0.20 × 106 |
| BZK | 3.48 ± 0.10 × 106 |
| PHMB | 3.49 ± 0.55 × 106 |
| MediHoney | 3.81 ± 0.32 × 106 |